Literature DB >> 27093049

Correction: Sialic Acid Metabolic Engineering: A Potential Strategy for the Neuroblastoma Therapy.

Vinayaga S Gnanapragassam, Kaya Bork, Christina E Galuska, Sebastian P Galuska, Dagobert Glanz, Manimozhi Nagasundaram, Matthias Bache, Dirk Vordermark, Guido Kohla, Christoph Kannicht, Roland Schauer, Rüdiger Horstkorte.   

Abstract

Entities:  

Year:  2016        PMID： 27093049      PMCID： PMC4836745          DOI： 10.1371/journal.pone.0154289

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The following information is missing from the Funding section: “This work was supported by a grant of the von Behring-Roentgen-Stiftung to SPG.”
  1 in total

1.  Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.

Authors:  Vinayaga S Gnanapragassam; Kaya Bork; Christina E Galuska; Sebastian P Galuska; Dagobert Glanz; Manimozhi Nagasundaram; Matthias Bache; Dirk Vordermark; Guido Kohla; Christoph Kannicht; Roland Schauer; Rüdiger Horstkorte
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240
  1 in total
  1 in total

1.  Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines.

Authors:  Paul R Wratil; Rüdiger Horstkorte
Journal:  J Vis Exp       Date:  2017-11-25       Impact factor: 1.355
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.